$MYGN
MYRIAD GENETICS INC Stock $mygn

$mygn Overview Financials Valuation SEC Filings Company Website

2013 Form 10-K Financial Statement

#000119312513334245 Filed on August 14, 2013

Income Statement

Concept	2013	2012 Q2	2012
Revenue	$613.2M	$133.0M	$496.0M
YoY Change	23.63%	23.84%	23.36%
Cost Of Revenue	$64.40M	$17.00M	$51.45M
YoY Change	25.17%	36.0%	12.74%
Gross Profit	$548.8M	$116.0M	$444.6M
YoY Change	23.45%	22.23%	24.72%
Gross Profit Margin	89.5%	87.22%	89.63%
Selling, General & Admin	$251.8M	$56.60M	$208.4M
YoY Change	20.84%	28.93%	22.69%
% of Gross Profit	45.88%	48.79%	46.87%
Research & Development	$53.70M	$12.10M	$42.65M
YoY Change	25.92%	31.52%	53.67%
% of Gross Profit	9.78%	10.43%	9.59%
Depreciation & Amortization	$8.889M	$2.400M	$9.069M
YoY Change	-1.98%	26.32%	25.63%
% of Gross Profit	1.62%	2.07%	2.04%
Operating Expenses	$305.5M	$68.70M	$251.0M
YoY Change	21.7%	29.38%	27.04%
Operating Profit	$228.0M	$47.30M	$180.3M
YoY Change	26.44%	13.16%	14.29%
Interest Expense	$5.500M	$1.400M	$4.600M
YoY Change	19.57%	250.0%	109.09%
% of Operating Profit	2.41%	2.96%	2.55%
Other Income/Expense, Net	$5.300M	-$200.0K	$4.222M
YoY Change	25.53%	100.0%	125.41%
Pretax Income	$233.3M	$48.50M	$189.7M
YoY Change	22.98%	15.2%	18.82%
Income Tax	$86.10M	$19.30M	$72.39M
% Of Pretax Income	36.91%	39.79%	38.16%
Net Earnings	$147.2M	$29.10M	$112.2M
YoY Change	31.25%	11.92%	11.36%
Net Earnings / Revenue	24.01%	21.88%	22.61%
Basic Earnings Per Share	$1.82		$1.33
Diluted Earnings Per Share	$1.77	$337.2K	$1.30
COMMON SHARES
Basic Shares Outstanding	80.90M shares		84.61M shares
Diluted Shares Outstanding	83.30M shares		86.47M shares

Balance Sheet

Concept	2013	2012 Q2	2012
SHORT-TERM ASSETS
Cash & Short-Term Investments	$372.3M	$340.5M	$340.5M
YoY Change	9.34%	-1.73%	-1.73%
Cash & Equivalents	$104.1M	$86.40M	$52.10M
Short-Term Investments	$268.2M	$254.2M	$254.2M
Other Short-Term Assets	$9.700M	$7.300M	$7.300M
YoY Change	32.88%	-42.52%	-42.52%
Inventory	$5.000M	$11.57M	$11.60M
Prepaid Expenses		$1.713M
Receivables	$94.30M	$60.44M	$60.40M
Other Receivables	$2.700M	$2.700M	$2.700M
Total Short-Term Assets	$484.0M	$422.5M	$422.5M
YoY Change	14.56%	1.01%	1.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.60M	$24.23M	$24.20M
YoY Change	14.05%	4.99%	4.76%
Goodwill		$56.85M
YoY Change		1.43%
Intangibles		$15.72M
YoY Change		-5.94%
Long-Term Investments	$158.7M	$113.7M	$113.7M
YoY Change	39.58%	60.37%	60.37%
Other Assets	$41.60M	$38.60M	$38.60M
YoY Change	7.77%	49.03%	49.03%
Total Long-Term Assets	$319.8M	$268.1M	$268.1M
YoY Change	19.28%	39.25%	39.27%
TOTAL ASSETS
Total Short-Term Assets	$484.0M	$422.5M	$422.5M
Total Long-Term Assets	$319.8M	$268.1M	$268.1M
Total Assets	$803.8M	$690.6M	$690.6M
YoY Change	16.39%	13.07%	13.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.10M	$10.14M	$10.10M
YoY Change	79.21%	-11.0%	-11.4%
Accrued Expenses	$44.30M	$32.77M	$32.80M
YoY Change	35.06%	51.41%	51.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$64.50M	$44.97M	$45.00M
YoY Change	43.33%	30.77%	30.81%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$10.70M	$10.00M	$10.00M
YoY Change	7.0%	4.17%	4.17%
Total Long-Term Liabilities	$10.70M	$10.00M	$10.00M
YoY Change	7.0%	4.17%	4.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$64.50M	$44.97M	$45.00M
Total Long-Term Liabilities	$10.70M	$10.00M	$10.00M
Total Liabilities	$75.20M	$54.98M	$55.00M
YoY Change	36.73%	24.84%	25.0%
SHAREHOLDERS EQUITY
Retained Earnings		-$12.68M
YoY Change		-67.17%
Common Stock		$826.0K
YoY Change		-4.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$728.6M	$635.8M	$635.7M
YoY Change
Total Liabilities & Shareholders Equity	$803.8M	$690.6M	$690.6M
YoY Change	16.39%	13.07%	13.06%

Cashflow Statement

Concept	2013	2012 Q2	2012
OPERATING ACTIVITIES
Net Income	$147.2M	$29.10M	$112.2M
YoY Change	31.25%	11.92%	11.36%
Depreciation, Depletion And Amortization	$8.889M	$2.400M	$9.069M
YoY Change	-1.98%	26.32%	25.63%
Cash From Operating Activities	$173.9M	$41.70M	$141.8M
YoY Change	22.61%	14.88%	8.39%
INVESTING ACTIVITIES
Capital Expenditures	-$11.40M	-$2.300M	-$10.30M
YoY Change	10.68%	91.67%	74.58%
Acquisitions			$799.0K
YoY Change			-98.99%
Other Investing Activities	-$64.20M	-$5.900M	-$28.60M
YoY Change	124.48%	-90.12%	-41.03%
Cash From Investing Activities	-$75.59M	-$8.200M	-$38.89M
YoY Change	94.38%	-86.54%	-28.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$146.3M		$128.5M
YoY Change	13.88%		-35.92%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-80.56M	-52.00M	-69.25M
YoY Change	16.33%	-625.25%	-40.61%
NET CHANGE
Cash From Operating Activities	173.9M	41.70M	141.8M
Cash From Investing Activities	-75.59M	-8.200M	-38.89M
Cash From Financing Activities	-80.56M	-52.00M	-69.25M
Net Change In Cash	17.72M	-18.50M	33.67M
YoY Change	-47.37%	25.85%	-183.84%
FREE CASH FLOW
Cash From Operating Activities	$173.9M	$41.70M	$141.8M
Capital Expenditures	-$11.40M	-$2.300M	-$10.30M
Free Cash Flow	$185.3M	$44.00M	$152.1M
YoY Change	21.8%	17.33%	11.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80446692	shares
CY2010Q3	mygn	Common Stock Authorized For Repurchase Expiration Date CommonStockAuthorizedForRepurchaseExpirationDate	2011-02
CY2011Q3	mygn	Common Stock Authorized For Repurchase Expiration Date CommonStockAuthorizedForRepurchaseExpirationDate	2013-01
CY2011Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	25000000
CY2012Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.07	pure
CY2012Q4	dei	Entity Public Float EntityPublicFloat	2209171779
CY2011Q1	mygn	Common Stock Authorized For Repurchase Expiration Date CommonStockAuthorizedForRepurchaseExpirationDate	2011-09
CY2010Q2	mygn	Common Stock Authorized For Repurchase Expiration Date CommonStockAuthorizedForRepurchaseExpirationDate	2010-08
CY2010Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.03
CY2010Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14116938	shares
CY2010Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4400000
CY2010Q2	us-gaap	Stockholders Equity StockholdersEquity	557581000
CY2010Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92840000
CY2010Q2	mygn	Unrecognized Tax Benefits Net Of Federal Benefits On State Income Tax Positions And Interest UnrecognizedTaxBenefitsNetOfFederalBenefitsOnStateIncomeTaxPositionsAndInterest	9797000
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7794782	shares
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.22
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14453913	shares
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	18.10
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13662687	shares
CY2011Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3700000
CY2011Q2	us-gaap	Stockholders Equity StockholdersEquity	566792000
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52681000
CY2011Q2	mygn	Unrecognized Tax Benefits Net Of Federal Benefits On State Income Tax Positions And Interest UnrecognizedTaxBenefitsNetOfFederalBenefitsOnStateIncomeTaxPositionsAndInterest	9648000
CY2011Q2	mygn	Reversal Of Additional Valuation Allowance ReversalOfAdditionalValuationAllowance	35024000
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82569000	shares
CY2012Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	8397678	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.32
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15233281	shares
CY2012Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.53
CY2012Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	19.28
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.01
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2012Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	14514637	shares
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82569000	shares
CY2012Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4600000
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	44967000
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-162000
CY2012Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10008000
CY2012Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	48297000
CY2012Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	647680000
CY2012Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	10141000
CY2012Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6613000
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	635660000
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12684000
CY2012Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2054000
CY2012Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2012Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32772000
CY2012Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4600000
CY2012Q2	us-gaap	Liabilities Liabilities	54975000
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	826000
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	690635000
CY2012Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	113692000
CY2012Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1713000
CY2012Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7781000
CY2011	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1876303	shares
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.027	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	26.09
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.021	pure
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8666000	shares
CY2012Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	42833000
CY2012Q2	us-gaap	Goodwill Goodwill	56850000
CY2012Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	21353000
CY2012Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	17800000
CY2012Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	5365000
CY2012Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15722000
CY2012Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60441000
CY2012Q2	us-gaap	Inventory Net InventoryNet	11574000
CY2012Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2781000
CY2012Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	36220000
CY2012Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	72528000
CY2012Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	5572000
CY2012Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	54728000
CY2012Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	126595000
CY2012Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	80000
CY2012Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1725000
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24231000
CY2012Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	30648000
CY2012Q2	us-gaap	Assets Assets	690635000
CY2012Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	420007000
CY2012Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	1350000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	86352000
CY2012Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1553000
CY2012Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	125245000
CY2012Q2	us-gaap	Other Assets OtherAssets	8000000
CY2012Q2	us-gaap	Notes Receivable Net NotesReceivableNet	19000000
CY2012Q2	us-gaap	Other Receivables OtherReceivables	2660000
CY2012Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	979000
CY2012Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	254180000
CY2012Q2	us-gaap	Assets Current AssetsCurrent	422492000
CY2012Q2	mygn	Residual Value Of Loan Agreement ResidualValueOfLoanAgreement	17000000
CY2012Q2	mygn	Unrecognized Tax Benefits Net Of Federal Benefits On State Income Tax Positions And Interest UnrecognizedTaxBenefitsNetOfFederalBenefitsOnStateIncomeTaxPositionsAndInterest	10208000
CY2012Q2	mygn	Deferred Tax Assets Uncertain State Tax Positions DeferredTaxAssetsUncertainStateTaxPositions	1216000
CY2012Q2	mygn	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments	66000
CY2012Q2	mygn	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestments	150000
CY2012Q2	mygn	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLossesAccumulatedInInvestments	216000
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80577000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7480472	shares
CY2013Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	14434970	shares
CY2013Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.06	pure
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.75
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	73180000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14434970	shares
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	21.58
CY2013Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	20.51
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	20.51
CY2013Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	7480472	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13543852	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80577000	shares
CY2013Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	7500000
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	9446000
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	64509000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-424000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	30455000
CY2013Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10718000
CY2013Q2	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	1424000
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	56595000
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	697346000
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	18132000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	8959000
CY2013Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8218000
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	728594000
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	30866000
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2043000
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44334000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	9642000
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7500000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5684000
CY2013Q2	us-gaap	Liabilities Liabilities	75227000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	8994000
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	806000
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	803821000
CY2013Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	158748000
CY2013Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	956000
CY2013Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8336000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	978000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	978000
CY2013Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	8007000
CY2013Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	65903000
CY2013Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	229900000
CY2013Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	44857000
CY2013Q2	us-gaap	Goodwill Goodwill	56850000
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	21135000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	268184000
CY2013Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	18294000
CY2013Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	5367000
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13330000
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	94333000
CY2013Q2	us-gaap	Inventory Net InventoryNet	5007000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	978000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	158748000
CY2013Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3103000
CY2013Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	36639000
CY2013Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	84197000
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	169829000
CY2013Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	205000
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2771000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27602000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	978000
CY2013Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	28632000
CY2013Q2	us-gaap	Assets Assets	803821000
CY2013Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	490652000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	53154000
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104073000
CY2013Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1424000
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	169829000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4890000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	81063000
CY2013Q2	us-gaap	Other Assets OtherAssets	13000000
CY2013Q2	us-gaap	Notes Receivable Net NotesReceivableNet	21667000
CY2013Q2	us-gaap	Other Receivables OtherReceivables	3373000
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	1269000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	978000
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	34445000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	159248000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	268243000
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	99648000
CY2013Q1	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	200000000
CY2013Q1	mygn	Share Repurchase Program Commencement Date ShareRepurchaseProgramCommencementDate	2013-02
CY2013Q1	mygn	Repurchase Program Date Completed Description RepurchaseProgramDateCompletedDescription	ongoing
CY2013Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	46620000
CY2010Q3	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	100000000
CY2010Q3	mygn	Share Repurchase Program Commencement Date ShareRepurchaseProgramCommencementDate	2010-08
CY2011Q3	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	200000000
CY2011Q3	mygn	Share Repurchase Program Commencement Date ShareRepurchaseProgramCommencementDate	2011-08
CY2011Q1	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	100000000
CY2011Q1	mygn	Share Repurchase Program Commencement Date ShareRepurchaseProgramCommencementDate	2011-03
CY2013Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	268243000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	531497000
CY2013Q2	us-gaap	Assets Current AssetsCurrent	483992000
CY2013Q2	mygn	Residual Value Of Loan Agreement ResidualValueOfLoanAgreement	17000000
CY2013Q2	mygn	Foreign Net Operating Loss Carry Forwards ForeignNetOperatingLossCarryForwards	16331000
CY2013Q2	mygn	Unrecognized Tax Benefits Net Of Federal Benefits On State Income Tax Positions And Interest UnrecognizedTaxBenefitsNetOfFederalBenefitsOnStateIncomeTaxPositionsAndInterest	10918000
CY2013Q2	mygn	Offsetting Valuation Allowance Federal OffsettingValuationAllowanceFederal	3786000
CY2013Q2	mygn	Fair Value Option Loans Aggregate Principal Amount Outstanding FairValueOptionLoansAggregatePrincipalAmountOutstanding	8000000
CY2013Q2	mygn	Deferred Tax Assets Uncertain State Tax Positions DeferredTaxAssetsUncertainStateTaxPositions	1247000
CY2013Q2	mygn	Total Federal And Alternative Minimum Tax Net Operating Loss Carry Forwards TotalFederalAndAlternativeMinimumTaxNetOperatingLossCarryForwards	3753000
CY2013Q2	mygn	Cash And Cash Equivalents And Available For Sale Securities Debt Maturities Estimated Fair Value CashAndCashEquivalentsAndAvailableForSaleSecuritiesDebtMaturitiesEstimatedFairValue	531064000
CY2013Q2	mygn	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments	587000
CY2013Q2	mygn	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLossesAccumulatedInInvestments	587000
CY2010Q2	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	100000000
CY2010Q2	mygn	Share Repurchase Program Commencement Date ShareRepurchaseProgramCommencementDate	2010-05
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.12
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3102440	shares
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91704000	shares
CY2011	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1910000	shares
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	17.63
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	145000	shares
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.009	pure
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.370	pure
CY2011	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	9824000	shares
CY2011	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-148000
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.021	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.61
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	130830000
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-116599000
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	25088000
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.06
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89794000	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	889162	shares
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.003	pure
CY2011	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3792000
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	6000
CY2011	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-31653000
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	2226000
CY2011	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	202000
CY2011	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	425153000
CY2011	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9091000
CY2011	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-4000
CY2011	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-353000
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	79417000
CY2011	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-53156000
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1873000
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	58831000
CY2011	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3000
CY2011	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	16183000
CY2011	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	400046000
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	35024000
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	159651000
CY2011	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6000
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14918000
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	848000
CY2011	us-gaap	Revenues Revenues	402084000
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	100722000
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	157778000
CY2011	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	2000000
CY2011	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	2038000
CY2011	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	412000
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200490000
CY2011	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	100000
CY2011	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	58831000
CY2011	us-gaap	Net Income Loss NetIncomeLoss	100710000
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-203000
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	12000
CY2011	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	25060000
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25088000
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5675000
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	244306000
CY2011	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	353000
CY2013	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11373000
CY2011	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	27370000
CY2011	us-gaap	Cost Of Revenue CostOfRevenue	45637000
CY2011	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-159973000
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	58831000
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	924000
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	287000
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	16182000
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-40159000
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3444000
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5548000
CY2011	us-gaap	Other Noncash Expense OtherNoncashExpense	2000000
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	61172000
CY2011	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	2283000
CY2011	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	322000
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	169841000
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58941000
CY2011	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-2304000
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-425000
CY2011	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	200490000
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	20215000
CY2011	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	16883000
CY2011	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1979000
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7219000
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	997000
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	386000
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	64616000
CY2011	us-gaap	Depreciation Depreciation	6833000
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	807000
CY2011	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	456072000
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54390000
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27751000
CY2011	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1077000
CY2011	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	25060000
CY2011	mygn	Concentration Risk Percentage Of Revenue ConcentrationRiskPercentageOfRevenue	0.10	pure
CY2011	mygn	Segment Reporting Depreciation And Amortization SegmentReportingDepreciationAndAmortization	7219000
CY2011	mygn	Amount Of Reduction In Common Stock As Result Of Stock Repurchases AmountOfReductionInCommonStockAsResultOfStockRepurchases	71615000
CY2011	mygn	Decrease In Valuation Allowance Attributable To Capital Losses DecreaseInValuationAllowanceAttributableToCapitalLosses	31653000
CY2011	mygn	Amount Charged To Retained Earnings As Result Of Stock Repurchases AmountChargedToRetainedEarningsAsResultOfStockRepurchases	128875000
CY2011	mygn	Income Tax Rate Reconciliation Change In Valuation Allowance IncomeTaxRateReconciliationChangeInValuationAllowance	-29349000
CY2011	mygn	Change In Valuation Allowance Attributable To Income Tax Expense Benefit ChangeInValuationAllowanceAttributableToIncomeTaxExpenseBenefit	-3371000
CY2013	dei	Trading Symbol TradingSymbol	MYGN
CY2013	dei	Entity Registrant Name EntityRegistrantName	MYRIAD GENETICS INC
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0000899923
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.82
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2957623	shares
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.77
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83327000	shares
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2379000	shares
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	27.09
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.008	pure
CY2013	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	The loan will mature on the earlier of (i) September 8, 2017 or (ii) the third anniversary following the date that the Company's option to acquire Crescendo under the Option Agreement expires or; otherwise terminates under the terms of the agreement. The option can be accelerated by Crescendo as a result of (a) Crescendo's delivery of an early termination notice due to the achievement of triggering events under the Option Agreement or (b) Crescendo's delivery of an initial public offering notice
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	149000	shares
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.010	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.369	pure
CY2013	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	5632000	shares
CY2013	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	710000
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.007	pure
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-257000
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	5497000
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	80333000
CY2013	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	3450000
CY2013	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	10280000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.87
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	173866000
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3490495	shares
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.017	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	22.26
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	15.65
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.005	pure
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5136000	shares
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="4%"><font size="1"> </font></td> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>(k)</i></b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></td> </tr> </table> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 8%"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires Company management to make estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the carrying amount of fixed assets, valuation allowances for receivables and deferred income tax assets, certain accrued liabilities, share-based compensation and impairment analysis of goodwill and intangible assets. Actual results could differ from those estimates.</font></p> </div>
CY2013	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80948000	shares
CY2013	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	Segment
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	265439	shares
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.002	pure
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y8M1D
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	7286907	shares
CY2013	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y11M19D
CY2013	mygn	Employers Contribution Not To Exceed Percentage Of Employees Compensation EmployersContributionNotToExceedPercentageOfEmployeesCompensation	0.04	pure
CY2013	mygn	Percent Of Employee Contribution To Deferred Savings Plan PercentOfEmployeeContributionToDeferredSavingsPlan	0.50	pure
CY2013	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	706000
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	443777000
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	80317000
CY2013	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	433000
CY2013	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-223000
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-7469000
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5274000
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	7888000
CY2013	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	165000
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	33294000
CY2013	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	582392000
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1605000
CY2013	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2667000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	233276000
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5000
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	67185000
CY2013	us-gaap	Revenues Revenues	613165000
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	710000
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	146877000
CY2013	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	5000000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	228002000
CY2013	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	30773000
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-757000
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-8000
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	146268000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	7888000
CY2013	us-gaap	Net Income Loss NetIncomeLoss	147139000
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6567000
CY2013	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	700000000
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-262000
CY2013	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	57825000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	26612000
CY2013	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1490000
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-217000
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	385163000
CY2013	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	223000
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-80555000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	26612000
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	33294000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	17721000
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6021000
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	8155000
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	180318000
CY2012	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	750000
CY2012	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	23615000
CY2012	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1204000
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	384560000
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-194000
CY2012	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	8000000
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	251839000
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	86137000
CY2013	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1822000
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-11000
CY2013	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	146268000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	51785000
CY2013	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	30394000
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	11562000
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7991000
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	660000
CY2013	us-gaap	Cumulative Effect On Retained Earnings Tax1 CumulativeEffectOnRetainedEarningsTax1	0
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	64376000
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-431000
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8889000
CY2013	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-243556000
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	7888000
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	895000
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	86354000
CY2013	us-gaap	Depreciation Depreciation	7994000
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	885000
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2051000
CY2013	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	270000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-75590000
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	53706000
CY2013	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	15242000
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	57825000
CY2013	mygn	Debt Instruments Maturity Date DebtInstrumentsMaturityDate	September 8, 2017
CY2013	mygn	Concentration Risk Percentage Of Revenue ConcentrationRiskPercentageOfRevenue	0.10	pure
CY2013	mygn	Federal And Alternative Minimum Tax Net Operating Loss Carry Forwards Expiration Dates FederalAndAlternativeMinimumTaxNetOperatingLossCarryForwardsExpirationDates	2030 through 2031
CY2013	mygn	Term Of Loan TermOfLoan	6	Y
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	184540000
CY2013	mygn	Deferred Tax Assets Tax Credit Carry Forwards General Business Expiration Date DeferredTaxAssetsTaxCreditCarryForwardsGeneralBusinessExpirationDate	2022 through 2028
CY2013	mygn	State And Local Net Operating Loss Carry Forwards Expiration Dates StateAndLocalNetOperatingLossCarryForwardsExpirationDates	2015 through 2025
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	128467000
CY2012	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	100000
CY2012	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	34193000
CY2012	us-gaap	Net Income Loss NetIncomeLoss	112151000
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3426000
CY2013	mygn	Segment Reporting Depreciation And Amortization SegmentReportingDepreciationAndAmortization	8889000
CY2013	mygn	Amount Of Reduction In Common Stock As Result Of Stock Repurchases AmountOfReductionInCommonStockAsResultOfStockRepurchases	42679000
CY2013	mygn	Income Related To Accretion Of Note Receivable And Stated Interest Rate IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate	4411000
CY2013	mygn	Effective Period Of Option EffectivePeriodOfOption	3	Y
CY2013	mygn	Amount Charged To Retained Earnings As Result Of Stock Repurchases AmountChargedToRetainedEarningsAsResultOfStockRepurchases	103589000
CY2013	mygn	Percentage Of Additional Interest On Defaults Payments PercentageOfAdditionalInterestOnDefaultsPayments	0.05	pure
CY2013	mygn	Income Tax Rate Reconciliation Change In Valuation Allowance IncomeTaxRateReconciliationChangeInValuationAllowance	1822000
CY2013	mygn	Change In Valuation Allowance Attributable To Income Tax Expense Benefit ChangeInValuationAllowanceAttributableToIncomeTaxExpenseBenefit	1605000
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-178000
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34986000
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3188160	shares
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.30
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86465000	shares
CY2012	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1857000	shares
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.42
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.006	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	161000	shares
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.013	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.392	pure
CY2012	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	5688000	shares
CY2012	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	560000
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.010	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.47
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	141804000
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1852245	shares
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.027	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	21.48
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.010	pure
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8585000	shares
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.94
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84608000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	556547	shares
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.002	pure
CY2012	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	9408000
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-135000
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	4629000
CY2012	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2312000
CY2012	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	388067000
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	33382000
CY2012	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-14000
CY2012	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-407000
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	799000
CY2012	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-33625000
CY2012	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	17000000
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4222000
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	34193000
CY2012	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	566000
CY2012	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	24742000
CY2012	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	472390000
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1851000
CY2012	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2000000
CY2012	mygn	Segment Reporting Depreciation And Amortization SegmentReportingDepreciationAndAmortization	9069000
CY2012	mygn	Amount Of Reduction In Common Stock As Result Of Stock Repurchases AmountOfReductionInCommonStockAsResultOfStockRepurchases	42262000
CY2012	mygn	Income Related To Accretion Of Note Receivable And Stated Interest Rate IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate	3250000
CY2012	mygn	Amount Charged To Retained Earnings As Result Of Stock Repurchases AmountChargedToRetainedEarningsAsResultOfStockRepurchases	86205000
CY2012	us-gaap	Revenues Revenues	496005000
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	560000
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	111838000
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-313000
CY2012	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	25029000
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	26275000
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	250000
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	315687000
CY2012	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	407000
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-69245000
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	26275000
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24742000
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	33671000
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4647000
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	6819000
CY2012	us-gaap	Other Noncash Expense OtherNoncashExpense	750000
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	67492000
CY2012	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	2955000
CY2012	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	5162000
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	208383000
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	72389000
CY2012	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1601000
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	748000
CY2012	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	128467000
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	21575000
CY2012	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	23842000
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	11218000
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1249000
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2192000
CY2012	us-gaap	Cost Of Revenue CostOfRevenue	51452000
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2326000
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9069000
CY2012	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-189702000
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	34193000
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1100000
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	72139000
CY2012	us-gaap	Depreciation Depreciation	7969000
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	892000
CY2012	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1735000
CY2012	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	385236000
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38888000
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42645000
CY2012	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	13207000
CY2012	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	25029000
CY2012	mygn	Concentration Risk Percentage Of Revenue ConcentrationRiskPercentageOfRevenue	0.10	pure
CY2012	mygn	Income Tax Rate Reconciliation Change In Valuation Allowance IncomeTaxRateReconciliationChangeInValuationAllowance	1601000
CY2012	mygn	Change In Valuation Allowance Attributable To Income Tax Expense Benefit ChangeInValuationAllowanceAttributableToIncomeTaxExpenseBenefit	1851000

Files In Submission

Name	View Source	Status
0001193125-13-334245-index-headers.html	Edgar Link	pending
0001193125-13-334245-index.html	Edgar Link	pending
0001193125-13-334245.txt	Edgar Link	pending
0001193125-13-334245-xbrl.zip	Edgar Link	pending
d540814d10k.htm	Edgar Link	pending
d540814dex211.htm	Edgar Link	pending
d540814dex231.htm	Edgar Link	pending
d540814dex311.htm	Edgar Link	pending
d540814dex312.htm	Edgar Link	pending
d540814dex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g540814g26g59.jpg	Edgar Link	pending
mygn-20130630.xml	Edgar Link	completed
mygn-20130630.xsd	Edgar Link	pending
mygn-20130630_cal.xml	Edgar Link	unprocessable
mygn-20130630_def.xml	Edgar Link	unprocessable
mygn-20130630_lab.xml	Edgar Link	unprocessable
mygn-20130630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R53.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R54.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R55.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R56.xml	Edgar Link	unprocessable
R57.htm	Edgar Link	pending
R57.xml	Edgar Link	unprocessable
R58.htm	Edgar Link	pending
R58.xml	Edgar Link	unprocessable
R59.htm	Edgar Link	pending
R59.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R60.htm	Edgar Link	pending
R60.xml	Edgar Link	unprocessable
R61.htm	Edgar Link	pending
R61.xml	Edgar Link	unprocessable
R62.htm	Edgar Link	pending
R62.xml	Edgar Link	unprocessable
R63.htm	Edgar Link	pending
R63.xml	Edgar Link	unprocessable
R64.htm	Edgar Link	pending
R64.xml	Edgar Link	unprocessable
R65.htm	Edgar Link	pending
R65.xml	Edgar Link	unprocessable
R66.htm	Edgar Link	pending
R66.xml	Edgar Link	unprocessable
R67.htm	Edgar Link	pending
R67.xml	Edgar Link	unprocessable
R68.htm	Edgar Link	pending
R68.xml	Edgar Link	unprocessable
R69.htm	Edgar Link	pending
R69.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R70.htm	Edgar Link	pending
R70.xml	Edgar Link	unprocessable
R71.htm	Edgar Link	pending
R71.xml	Edgar Link	unprocessable
R72.htm	Edgar Link	pending
R72.xml	Edgar Link	unprocessable
R73.htm	Edgar Link	pending
R73.xml	Edgar Link	unprocessable
R74.htm	Edgar Link	pending
R74.xml	Edgar Link	unprocessable
R75.htm	Edgar Link	pending
R75.xml	Edgar Link	unprocessable
R76.htm	Edgar Link	pending
R76.xml	Edgar Link	unprocessable
R77.htm	Edgar Link	pending
R77.xml	Edgar Link	unprocessable
R78.htm	Edgar Link	pending
R78.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MYGN
MYRIAD GENETICS INC Stock $mygn

2013 Form 10-K Financial Statement

#000119312513334245 Filed on August 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYGN MYRIAD GENETICS INC Stock $mygn

2013 Form 10-K Financial Statement

#000119312513334245 Filed on August 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYGN
MYRIAD GENETICS INC Stock $mygn